机译:Siglec9 Siglec9 Siglec9多态性对COPD COPD表型的影响,包括恶化频率
Respiratory Care ClinicNippon Medical SchoolTokyo Japan;
Institute of Biological ChemistryAcademia SinicaTaipei Taiwan;
Channing Division of Network MedicineBrigham and Women's HospitalBoston Massachusetts USA;
Channing Division of Network MedicineBrigham and Women's HospitalBoston Massachusetts USA;
Respiratory Care ClinicNippon Medical SchoolTokyo Japan;
Disease Glycomics Team Systems Glycobiology Research Group Global Research ClusterRIKENSaitama;
Department of Analytical biochemistry Faculty of Life SciencesKumamoto UniversityKumamoto Japan;
Disease Glycomics Team Systems Glycobiology Research Group Global Research ClusterRIKENSaitama;
Division of Pulmonary Medicine Infectious Diseases and Oncology Department of Internal;
University of British Columbia Center for Heart Lung InnovationUniversity of St Paul's;
UCL RespiratoryUniversity College LondonLondon UK;
Channing Division of Network MedicineBrigham and Women's HospitalBoston Massachusetts USA;
Disease Glycomics Team Systems Glycobiology Research Group Global Research ClusterRIKENSaitama;
Respiratory Care ClinicNippon Medical SchoolTokyo Japan;
chronic obstructive pulmonary disease; emphysema; genetics; in vitro assays; infection and inflammation;
机译:Siglec9 Siglec9 Siglec9多态性对COPD COPD表型的影响,包括恶化频率
机译:siglec家族新成员(SIGLEC9)的鉴定和分子表征。
机译:ADRB2基因多态性对沙美特罗和噻托溴铵预防COPD恶化的疗效的影响:POET-COPD试验的预先指定子研究
机译:影像学特征的多尺度分析及其在COPD加重易感表型研究中的应用
机译:高剂量N-乙酰半胱氨酸对COPD患者小型气道功能和恶化的影响
机译:大环内酯类维持疗法和细菌定植对加重频率和COPD进展的影响(COLUMBUS):一项随机对照试验的研究方案
机译:大环内酯类维持疗法和细菌定植对加重频率和COPD进展的影响(COLUMBUS):一项随机对照试验的研究方案